Results 61 to 70 of about 37,713 (238)

Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion

Saudi Pharmaceutical Journal, 2022
Purpose: The aim of this study was to design fast dissolving tablets (FDT) of the anti –psychiatric drug haloperidol in solid dispersion forms as a way to enhance its dissolution profile and anti-psychiatric effect.
Aya M. Eisa, Nagia A. El-Megrab, Hanan M. El-Nahas   +2 more
doaj  

THE INVESTIGATION OF INFLUENCE OF GENETIC PROFILE ON THE EFFICACY AND SAFETY OF HALOPERIDOL IN PATIENTS WITH ALCOHOL DEPENDENCE

Архивъ внутренней медицины, 2016
In case of patients with alcohol addiction haloperidol is used to control the exacerbation of the addiction, but the empirical dose selection of haloperidol often results in adverse side effects.
M. S. Zastrozhin, E. A. Grishina, D. A. Sychev, L. M. Savchenko, E. A. Bryun, M. V. Prudnikova, O. M. Saraeva, V. V. Trofimov   +7 more
doaj   +1 more source

Annual Research Review: Psychosis in children and adolescents: key updates from the past 2 decades on psychotic disorders, psychotic experiences, and psychosis risk

Journal of Child Psychology and Psychiatry, Volume 66, Issue 4, Page 460-476, April 2025.
Psychosis in children and adolescents has been studied on a spectrum from (common) psychotic experiences to (rare) early‐onset schizophrenia spectrum disorders. This research review looks at the state‐of‐the‐art for research across the psychosis spectrum, from evidence on psychotic experiences in community and clinical samples of children and ...
Ian Kelleher
wiley   +1 more source

Comparative Safety of Medications for Severe Agitation: A Geriatric Emergency Department Guidelines 2.0 Systematic Review

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Managing undifferentiated, severe agitation in older adults may require antipsychotic or sedative medications to prevent harm to self or others. Unfortunately, these medications are associated with serious adverse events in older adults, and little is known about their comparative safety.
Martin F. Casey, Natalie M. Elder, Alexander Fenn, Joshua Niznik, Danya Khoujah, Jon B. Cole, Zachary Cardon, Ming Ding, Naira Goukasian, Elizabeth Moreton, Jennifer L. Koehl, Phillip D. Magidson, Rachel M. Skains, Katren Tyler, Shan W. Liu, on behalf of the Geriatric Emergency Department Guidelines Medication Safety Group, Jane M. Hayes, Katherine Selman, Phraewa Thatphet, Kazuki Toda, Bryan D. Hayes, Sangil Lee   +21 more
wiley   +1 more source

Quetiapine versus Haloperidol in Controlling Conversion Disorder Symptoms; a Randomized Clinical Trial

Archives of Academic Emergency Medicine, 2018
Introduction: About 5% of visits to emergency departments are made up of conversion disorder cases. This study was designed with the aim of comparing the effectiveness of quetiapine and haloperidol in controlling conversion disorder symptoms.
Saeed Reza Ghanbarizadeh, Hossein Dinpanah, Reza Ghasemi, Yaser Salahshour, Samaneh Sardashti, Mostafa Kamali, Seyed Reza Khatibi   +6 more
doaj   +1 more source

Haloperidol-related neutropenia

Indian Journal of Psychiatry, 2019
Phenothiazines like antipsychotics have been known to cause neutropenia, but this has been reported very rarely with haloperidol. A 20-year-old male patient admitted to emergency service (emergency room) with shortness of breath, chest pain, and anger. He was diagnosed with pneumonia and prescribed moxifloxacin.
openaire   +5 more sources

Acute care of cyclic vomiting syndrome and cannabinoid hyperemesis syndrome in the home and emergency department

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
Abstract Background Cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS) are both characterized by episodic, acute transitions from asymptomatic states to highly symptomatic states of nausea, repetitive vomiting, and often severe abdominal pain.
David J. Levinthal, Blynda Killian, Robert M. Issenman   +2 more
wiley   +1 more source

The FDA Has Ended Required Blood Monitoring for Clozapine Use—Will This Impact the Management of Parkinson's Disease Psychosis?

Movement Disorders, EarlyView.
Daniel Weintraub, Izabelle Schoen
wiley   +1 more source

Endocannabinoid signaling in stress, nausea, and vomiting

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
Abstract Background Classical antiemetics that target the serotonin system may not be effective in treating certain nausea and vomiting conditions like cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS). As a result, there is a need for better therapies to manage the symptoms of these disorders, including nausea, vomiting, and ...
Marieka V. DeVuono, Thangam Venkatesan, Cecilia J. Hillard   +2 more
wiley   +1 more source

The effect of haloperidol on the sleep cycle of the cat [PDF]

, 1968
Jaime M. Monti
openalex   +1 more source